Search

Your search keyword '"Olivier Feron"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Olivier Feron" Remove constraint Author: "Olivier Feron" Topic biology Remove constraint Topic: biology
159 results on '"Olivier Feron"'

Search Results

1. Two isoprenylated flavonoids from Dorstenia psilurus activate AMPK, stimulate glucose uptake, inhibit glucose production and lower glycemia

2. Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

3. Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy

4. Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation

5. The many metabolic sources of acetyl-CoA to support histone acetylation and influence cancer progression

6. TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells

7. Tumour acidosis: from the passenger to the driver's seat

8. Ffar2 expression regulates leukaemic cell growth in vivo

9. Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling

10. Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors B-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Crosslinking with Michael Acceptor Motif-Containing Drugs

11. Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy

12. Cancer heterogeneity is not compatible with one unique cancer cell metabolic map

13. Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation

14. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells

15. Cycling hypoxia

16. Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)

17. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

18. A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT

19. Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth

20. Metabolic and mind shifts

21. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

22. Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Networks in Cancer

23. Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction

24. Emerging roles of lipid metabolism in cancer progression

25. The NLRP3 Inflammasome Has a Critical Role in Peritoneal Dialysis-Related Peritonitis

26. The SIRT1/HIF2α Axis Drives Reductive Glutamine Metabolism under Chronic Acidosis and Alters Tumor Response to Therapy

27. Hypoxia Modulates the Differentiation Potential of Stem Cells of the Apical Papilla

28. Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation

29. Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

30. Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation

31. PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation

32. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species

33. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice

34. Effects of BM-573 on Endothelial dependent relaxation and increased blood pressure at early stages of atherosclerosis

35. Erratum

36. Multimodality imaging identifies distinct metabolic profiles in vitro and in vivo

37. Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

38. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

39. Vascular Hypoxic Preconditioning Relies on TRPV4-Dependent Calcium Influx and Proper Intercellular Gap Junctions Communication

40. LDV peptidomimetics equipped with biotinylated spacer-arms: Synthesis and biological evaluation on CCRF-CEM cell line

41. Diaryl ureaLDV peptidomimetics as α4β1integrin antagonists: synthesis, adhesion inhibition and toxicity evaluation on CCRF-CEM cell line

42. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments

43. Preconditioned Endothelial Progenitor Cells Reduce Formation of Melanoma Metastases through SPARC-Driven Cell–Cell Interactions and Endocytosis

44. The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the ‘endothelium-derived hyperpolarizing factor’

45. Identification of Cyclooxygenase-2 as a Major Actor of the Transcriptomic Adaptation of Endothelial and Tumor Cells to Cyclic Hypoxia: Effect on Angiogenesis and Metastases

46. eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues

47. Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death

48. Impact of cyclic hypoxia on HIF-1α regulation in endothelial cells - new insights for anti-tumor treatments

49. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis

50. Iodine Deficiency Induces a Thyroid Stimulating Hormone-Independent Early Phase of Microvascular Reshaping in the Thyroid

Catalog

Books, media, physical & digital resources